Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study

BACKGROUND: The recent interferon-free direct-acting antiviral (DAA) regimens have very good safety and efficacy profiles and are highly recommended for kidney transplant (KT) recipients with chronic hepatitis C (CHC). METHODS: All KT recipients with CHC followed at our hospital and who received the...

Descripción completa

Detalles Bibliográficos
Autores principales: Darema, Maria, Cholongitas, Evangelos, Filiopoulos, Vassilis, Marinaki, Smaragdi, Pavlopoulou, Ioanna D., Tsoubou, Ioanna, Boletis, John N., Papatheodoridis, George V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196623/
https://www.ncbi.nlm.nih.gov/pubmed/32382232
http://dx.doi.org/10.20524/aog.2020.0481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196623/
https://www.ncbi.nlm.nih.gov/pubmed/32382232
http://dx.doi.org/10.20524/aog.2020.0481

Ejemplares similares